Barriers to implementation of primary percutaneous coronary intervention in Europe

European Cardiology

Volumn 7, Issue 2, 2011, Pages 108-112

  Laut, Kristina Grønborg ^a   Pedersen, Alma Becic ^a   Lash, Timothy L ^a   Kristensen, Steen Dalby ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute ST elevation myocardial infarction; Implementation; Practice variation; Primary percutaneous coronary intervention; Registry data

Indexed keywords

ACUTE HEART INFARCTION; ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ARTICLE; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DATA BASE; ELECTROCARDIOGRAM; EUROPE; FIBRINOLYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEART CATHETERIZATION; HUMAN; MEDICAL DOCUMENTATION; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PERSONNEL MANAGEMENT; PRIMARY PERCUTANEOUS CORONARY INTERVENTION; REGISTER; REIMBURSEMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; WORK EXPERIENCE;

EID: 84857517090     PISSN: 17583756     EISSN: 17583764     Source Type: Journal    
DOI: 10.15420/ecr.2011.7.2.108     Document Type: Article

References (70)

1. Allender S, Scarborough P, Peto V, et al., European cardiovascular disease statistics: European Heart Network; 2008. Available from: www.bhf.org.uk/hearthealth/ statistics.aspx (accessed 4 May 2011).
2. Kushner FG, Hand M, Smith SC Jr, et al., 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 2009;120:2271-306.
3. Van de Werf F, Bax J, Betriu A, et al., Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology, Eur Heart J, 2008;29:2909-45.
4. Andersen HR, Nielsen TT, Rasmussen K, et al., A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction, N Engl J Med, 2003;349:733-42.
5. Busk M, Maeng M, Rasmussen K, et al., The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up, Eur Heart J, 2008;29:1259-66.
6. Widimsky P, Budesinsky T, Vorac D, et al., Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2, Eur Heart J, 2003;24:94-104.
7. Widimsky P, Groch L, Zelizko M, et al., Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study, Eur Heart J, 2000;21:823-31.
8. Boersma E, Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients, Eur Heart J, 2006;27:779-88
9. Hartwell D, Colquitt J, Loveman E, et al., Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation, Health Technol Assess, 2005;9:1-99,iii-iv.
10. Kalla K, Christ G, Karnik R, et al., Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry), Circulation, 2006;113:2398-405.
11. Keeley EC, Boura JA, Grines CL, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet, 2003;361:13-20
12. Nallamothu BK, Antman EM, Bates ER, Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-totreatment?, Am J Cardiol, 2004;94:772-4
13. Zijlstra F, Patel A, Jones M, et al., Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction, Eur Heart J, 2002;23:550-7.
14. Antman EM, Hand M, Armstrong PW, et al., 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 2008;51:210-47.
15. Widimsky P, Wijns W, Fajadet J, et al., Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries, Eur Heart J, 2010;31:943-57.
16. Wijns W, Kolh P, Danchin N, et al., Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, 2010;31:2501-55.
17. Banta HD, Introduction. Minimally invasive therapy in five European countries: diffusion, effectiveness and cost-effectiveness, Health Policy (Amsterdam, Netherlands), 1993;23:1-5.
18. Banta HD, Vondeling H, Diffusion of minimally invasive therapy in Europe, Health Policy (Amsterdam, Netherlands), 1993;23:125-33
19. Birkmeyer JD, Sharp SM, Finlayson SR, et al., Variation profiles of common surgical procedures, Surgery, 1998;124:917-23.
20. Cabana MD, Rand CS, Powe NR, et al., Why don't physicians follow clinical practice guidelines? A framework for improvement, JAMA, 1999;282:1458-65.
21. Grol RP, Bosch MC, Hulscher ME, et al., Planning and studying improvement in patient care: the use of theoretical perspectives, The Milbank quarterly, 2007;85:93-138.
22. Hvelplund A, Galatius S, Madsen M, et al., Influence of distance from home to invasive centre on invasive treatment after acute coronary syndrome: a nationwide study of 24 910 patients, Heart, 2011;97:27-32.
23. Kramer JM, Newby LK, Chang WC, et al., International variation in the use of evidence-based medicines for acute coronary syndromes, Eur Heart J, 2003;24:2133-41.
24. Lomas J, Haynes RB, A taxonomy and critical review of tested strategies for the application of clinical practice recommendations: from "official" to "individual" clinical policy, Am J Prevent Med, 1988;4:77-94; discussion 5-7
25. Niemann T, Lous J, Thorsgaard N, et al., Regional variations in the use of diagnostic coronary angiography. A one-year population-based study of all diagnostic coronary angiographies performed in a rural and an urban Danish county, Scand Cardiovasc J, 2000;34:286-92.
26. OECD, A disease-based comparison of health systems, OECD Publishing; 2003. Available from: www.oecdbookshop.org/oecd/display.asp?K=5LMQCR2K4RWD&DS=A-Disease-based-Comparison-of-Health-Systems (accessed 4 May 2011).
27. Poulsen PB, Adamsen S, Vondeling H, et al., Diffusion of laparoscopic technologies in Denmark, Health Policy (Amsterdam, Netherlands), 1998;45:149-67.
28. Wennberg JE, Understanding geographic variations in health care delivery, N Engl J Med, 1999;340:52-3
29. Andrikopoulos G, Pipilis A, Goudevenos J, et al., Epidemiological characteristics, management and early outcome of acute myocardial infarction in Greece: the HELlenic Infarction Observation Study, Hellenic J Cardiol, 2007;48:325-34.
30. Balzi D, Barchielli A, Santoro GM, et al., Management of acute myocardial infarction in the real world: a summary report from The Ami-Florence Italian Registry, Intern Emerg Med, 2008;3:109-15.
31. Eagle KA, Nallamothu BK, Mehta RH, et al., Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go, Eur Heart J, 2008;29:609-17.
32. Gabriel Steg P, Iung B, Feldman LJ, et al., Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT, Eur Heart J, 2003;24:613-22.
33. Woods KL, Ketley D, Agusti A, et al., Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective, Eur Heart J, 1998;19:1348-54.
34. Oh EH, Imanaka Y, Evans E, Determinants of the diffusion of computed tomography and magnetic resonance imaging, Int J Technol Assess Health Care, 2005;21:73-80
35. Bakka J, Fivelsdal E, Organisational Theory, 5th edn, Copenhahen: Handelshøjskolens forlag; 2010
36. Terkelsen CJ, Sorensen JT, Maeng M, et al., System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention, JAMA, 2010;304:763-71.
37. Sorensen JT, Terkelsen CJ, Norgaard BL, et al., Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction, Eur Heart J, 2011;32:430-6.
38. Bradley EH, Roumanis SA, Radford MJ, et al., Achieving doorto-balloon times that meet quality guidelines: how do successful hospitals do it?, J Am Coll Cardiol, 2005;46:1236-41.
39. Graff LG, Wang Y, Borkowski B, et al., Delay in the diagnosis of acute myocardial infarction: effect on quality of care and its assessment, Acad Emerg Med, 2006;13:931-8.
40. Nallamothu BK, Bates ER, Wang Y, et al., Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction, Circulation, 2006;113:1189-95.
41. Terkelsen CJ, Christiansen EH, Sorensen JT, et al., Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time, Heart, 2009;95:362-9.
42. Goodacre S, Sampson F, Carter A, et al., Evaluation of the National Infarct Angioplasty Project: National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO), 2008.
43. Labinaz M, Swabey T, Watson R, et al., Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report, Can J Cardiol, 2006;22:243-50.
44. Dalby M, Bouzamondo A, Lechat P, et al., Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis, Circulation, 2003;108:1809-14.
45. Keeley EC, Grines CL, Primary percutaneous coronary intervention for every patient with ST-segment elevation myocardial infarction: what stands in the way?, Ann Intern Med, 2004;141:298-304
46. Terkelsen CJ, Lassen JF, Norgaard BL, et al., Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention, Eur Heart J, 2005;26:770-7.
47. Halvorsen S, Huber K, The role of fibrinolysis in the era of primary percutaneous coronary intervention, Thromb Haemost, 2011;105(3):390 -5. Epub 6 Dec 2010.
48. Fye WB, Introduction: the origins and implications of a growing shortage of cardiologists, J Am Coll Cardiol, 2004;44:221-32
49. Person SD, Allison JJ, Kiefe CI, et al., Nurse staffing and mortality for Medicare patients with acute myocardial infarction, Med Care, 2004;42:4-12.
50. Guadagnoli E, Landrum MB, Normand SL, et al., Impact of underuse, overuse, and discretionary use on geographic variation in the use of coronary angiography after acute myocardial infarction, Med Care, 2001;39:446-58.
51. Guadagnoli E, Landrum MB, Peterson EA, et al., Appropriateness of coronary angiography after myocardial infarction among Medicare beneficiaries. Managed care versus fee for service, N Engl J Med, 2000;343:1460-6.
52. Kansagra SM, Curtis LH, Schulman KA, Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance, JAMA, 2004;292:1717-23
53. Rathore SS, Epstein AJ, Nallamothu BK, et al., Regionalization of ST-segment elevation acute coronary syndromes care: putting a national policy in proper perspective, J Am Coll Cardiol, 2006;47:1346-9.
54. Carter A, Wood S, Goodacre S, et al., Evaluation of workforce and organizational issues in establishing primary angioplasty in England, J Health Serv Res Po, 2010;15:6-13.
55. Haynes RB, Hayward RS, Lomas J, Bridges between health care research evidence and clinical practice, JAMA, 1995;2:342-50
56. Ziegenfuss JT Jr, Organizational barriers to quality improvement in medical and health care organizations, Qual Assur Util Rev, 1991;6:115-22
57. Wright JG, Hidden barriers to improvement in the quality of health care, N Engl J Med, 2002;346:1096.
58. Selmer R, Halvorsen S, Myhre KI, et al., Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction, Scand Cardiovasc J, 2005;39:276-85.
59. Aasa M, Henriksson M, Dellborg M, et al., Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction - results of the Swedish Early Decision reperfusion Study (SWEDES) trial, Am Heart J, 2010;160:322-8.
60. Mensah GA, Hand MM, Antman EM, et al., Development of systems of care for ST-elevation myocardial infarction patients: the patient and public perspective, Circulation, 2007;116:e33-8.
61. Rokos IC, Larson DM, Henry TD, et al., Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks, Am Heart J, 2006;152:661-7.
62. Ayanian JZ, Landrum MB, Guadagnoli E, et al., Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction, N Engl J Med, 2002;347:1678-86.
63. Battista RN, Innovation and diffusion of health-related technologies. A conceptual framework, Int J Technol Assess Health Care, 1989;5:227-48.
64. Garg PP, Landrum MB, Normand SL, et al., Understanding individual and small area variation in the underuse of coronary angiography following acute myocardial infarction, Med Care, 2002;40:614-26.
65. Alpert JS, Are data from clinical registries of any value?, Eur Heart J, 2000;21:1399-401
66. Kramer JM, Newby LK, Chang WC, et al., International variation in the use of evidence-based medicines for acute coronary syndromes, Eur Heart J, 2003;24:2133-41.
67. Spertus JA, Radford MJ, Every NR, et al., Challenges and opportunities in quantifying the quality of care for acute myocardial infarction: summary from the Acute Myocardial Infarction Working Group of the American Heart Association/American College of Cardiology First Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, J Am Coll Cardiol, 2003;41:1653-63.
68. Norredam M, Nielsen SS, Krasnik A, Migrants' utilization of somatic healthcare services in Europe-a systematic review, Eur J Public Health, 2010;20:555-63
69. Havelin LI, Fenstad AM, Salomonsson R, et al., The Nordic Arthroplasty Register Association: a unique collaboration between 3 national hip arthroplasty registries with 280,201 THRs, Acta Orthop, 2009;80:393-401.
70. Widimsky P, Fajadet J, Danchin N, et al., "Stent 4 Life" targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac Care, EuroIntervention, 2009;4:555-7.